Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Nano Letters|February 22, 2022
Electron Dynamics in Hybrid Perovskites Reveal the Role of Organic Cations on the Screening of Local ChargesMarie Cherasse, Jingwei Dong, Gaëlle Trippé-Allard, et al.
ACS Nano|November 3, 2023
A Bifunctional Optoelectronic Device for Photodetection and Photoluminescence Switching Based on Graphene/ZnTe/Graphene van der Waals HeterostructuresYushu Wang, Zhesheng Chen, Yan Qu, et al.
Nano Letters|January 18, 2023
Manipulating Dirac States in BaNiS2 by Surface Charge DopingJiuxiang Zhang, Thibault Daniel Pierre Sohier, Michele Casula, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 6, 2025
PD-L1 on Tumor-Derived Extracellular Vesicles Induces CD8+ T Cell Terminal Exhaustion and Mediates Anti-PD-1 Resistance in Head and Neck Squamous Cell CarcinomaRuihua Fang, Bixue Huang, Yun Li, et al.
Nature Communications|January 17, 2025
Rotation symmetry mismatch and interlayer hybridization in MoS2-black phosphorus van der Waals heterostructuresZailan Zhang, Alberto Zobelli, Chaofeng Gao, et al.
Nano Letters|April 3, 2025
2D In2Ge2Te6 Crystals for High-Performance p-Channel TransistorsTong Zhao, Shiying Guo, Xiufeng Song, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesityRichard Berger, Cheng Zhu, Alexa R Hansen, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Discovery of imidazole carboxamides as potent and selective CCK1R agonistsCheng Zhu, Alexa R Hansen, Thomas Bateman, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Pageof 4